CIN 2 Meaning: Is Treatment Always Needed After Colposcopy?

CIN 2 means a biopsy found moderate abnormal changes in the surface cells of the cervix. It is not cancer. It is counted as a high-grade change, so treatment to remove the cells is often offered, but CIN 2 can sometimes clear by itself and close monitoring is an option for some people.

CIN stands for cervical intraepithelial neoplasia. It describes abnormal-looking cells confined to the lining of the cervix. The grade, from 1 to 3, reflects how abnormal the cells look and how much of the lining is affected. Cleveland Clinic describes CIN 2 as affecting about one-third to two-thirds of the lining's thickness.

This guide explains the general options. Your colposcopy team will base the plan on your full results, age and preferences.

CIN 2 does not usually cause symptoms. Whether you are waiting for treatment or being monitored, the NHS advises seeing a GP or local clinician if you notice any of the following, or if symptoms change or get worse:

• Vaginal bleeding that is unusual for you, such as between periods, after sex or after the menopause.
• A change in your vaginal discharge.
• Pain during sex, or pain in your lower back, pelvis or lower tummy.
• After LLETZ: bleeding heavier than a heavy period, unpleasant-smelling discharge, or tummy pain that does not improve with painkillers. Contact your GP or NHS 111, or your local equivalent.

No. The NHS says CIN is not cancer, but there is a risk the cells could turn into cancer in the future if not treated. Higher grades are more likely to progress, which is why CIN 2 is taken more seriously than CIN 1.

Because CIN 2 can sometimes clear, guidance allows either treatment or careful monitoring in suitable cases. The NHS also notes that cell changes do not get worse while you wait for a colposcopy appointment.

Not always. The NHS says that with CIN 2 you may be offered either a follow-up colposcopy to check the cells, or treatment to remove them. The US National Cancer Institute says CIN 2 is typically treated but can sometimes go away on its own.

Monitoring usually means regular colposcopy, sometimes with biopsies. In England, national guidance describes colposcopy every 6 months when CIN 2 is managed this way. It also says the CIN 2 should cover a limited area, CIN 3 and anything more serious should have been ruled out, and treatment must be offered if the CIN 2 has not cleared within 24 months.

NCI similarly says CIN 2 must be treated if it progresses to CIN 3 or does not go away in 1 to 2 years. Monitoring only works if you can attend every appointment.

Age and pregnancy plans often shape the choice. The 2019 ASCCP guidelines in the United States state that for people younger than 25 with CIN 2, observation is preferred and treatment is acceptable.

The same guidelines say observation is acceptable for CIN 2 in people concerned about the possible effects of treatment on future pregnancy. NCI explains that, rarely, procedures to remove cervical tissue can weaken the cervix. Cleveland Clinic also advises discussing options with your provider if you are planning a pregnancy.

If you are pregnant now, ASCCP guidance says treatment of CIN 2 or CIN 3 during pregnancy is not recommended. Instead, surveillance colposcopy is usually offered during pregnancy, with a review no earlier than 4 weeks after the birth. The NHS confirms that colposcopy is safe in pregnancy.

LLETZ (large loop excision of the transformation zone) is the most common treatment in the UK. In the US it is usually called LEEP (loop electrosurgical excision procedure). A thin wire loop carrying an electrical current removes the affected area of the cervix.

The NHS says LLETZ removes about a fingernail-sized area, is done under local anaesthetic, usually takes about 15 minutes and is often done on the same day as colposcopy. Other options include a cone biopsy, which removes a larger piece, usually under general anaesthetic, and methods that destroy cells, such as laser or cold treatment.

Afterwards, mild period-like pain and some bleeding or discharge are common. The NHS says bleeding can last up to 4 weeks after LLETZ. You may be advised to avoid sex and to use pads rather than tampons or menstrual cups for a time. In England, a test of cure screening sample is usually offered about 6 months after treatment.

Bring your colposcopy letter and biopsy report. These questions can help you weigh up the options:

• Am I a suitable candidate for monitoring, or do you recommend treatment in my case? Why?
• If I choose monitoring, how often will I be seen, and what result would mean I need treatment?
• I would like to have children in future. How might treatment affect a pregnancy, and does that change your advice?
• If I have LLETZ or LEEP, what recovery should I expect and when is my follow-up test?
• I am pregnant. What checks will I have now, and when will this be reviewed after the birth?
• Who do I contact if I have heavy bleeding, smelly discharge or worsening pain?

On SameCase, patients and verified doctors share de-identified cases. Seeing how others with CIN 2 weighed treatment against monitoring, and the questions they raised, can help you decide what to ask your own team.

Other people's cases cannot tell you which option is right for you or predict your outcome. We suggest using them to prepare for the conversation, not to replace it.

Both paths aim to stop CIN 2 from progressing. Treatment usually resolves it in one step; monitoring avoids a procedure but needs regular visits. Your team can explain which suits your results and plans. Keep a note of each appointment date and result.